200 related articles for article (PubMed ID: 32652460)
1. Pretreatment apparent diffusion coefficient does not predict therapy response to neoadjuvant chemotherapy in breast cancer.
Surov A; Wienke A; Meyer HJ
Breast; 2020 Oct; 53():59-67. PubMed ID: 32652460
[TBL] [Abstract][Full Text] [Related]
2. Pretreatment Apparent Diffusion Coefficient Cannot Predict Histopathological Features and Response to Neoadjuvant Radiochemotherapy in Rectal Cancer: A Meta-Analysis.
Surov A; Pech M; Powerski M; Woidacki K; Wienke A
Dig Dis; 2022; 40(1):33-49. PubMed ID: 33662962
[TBL] [Abstract][Full Text] [Related]
3. Can apparent diffusion coefficient (ADC) distinguish breast cancer from benign breast findings? A meta-analysis based on 13 847 lesions.
Surov A; Meyer HJ; Wienke A
BMC Cancer; 2019 Oct; 19(1):955. PubMed ID: 31615463
[TBL] [Abstract][Full Text] [Related]
4. Diffusion-weighted MR imaging: pretreatment prediction of response to neoadjuvant chemotherapy in patients with breast cancer.
Park SH; Moon WK; Cho N; Song IC; Chang JM; Park IA; Han W; Noh DY
Radiology; 2010 Oct; 257(1):56-63. PubMed ID: 20851939
[TBL] [Abstract][Full Text] [Related]
5. Apparent Diffusion Coefficient Can Predict Response to Chemotherapy of Liver Metastases in Colorectal Cancer.
Drewes R; Pech M; Powerski M; Omari J; Heinze C; Damm R; Wienke A; Surov A
Acad Radiol; 2021 Nov; 28 Suppl 1():S73-S80. PubMed ID: 33008734
[TBL] [Abstract][Full Text] [Related]
6. Apparent Diffusion Coefficient for Distinguishing Between Malignant and Benign Lesions in the Head and Neck Region: A Systematic Review and Meta-Analysis.
Surov A; Meyer HJ; Wienke A
Front Oncol; 2019; 9():1362. PubMed ID: 31970081
[No Abstract] [Full Text] [Related]
7. Diffusion-weighted MRI in pretreatment prediction of response to neoadjuvant chemotherapy in patients with breast cancer.
Richard R; Thomassin I; Chapellier M; Scemama A; de Cremoux P; Varna M; Giacchetti S; Espié M; de Kerviler E; de Bazelaire C
Eur Radiol; 2013 Sep; 23(9):2420-31. PubMed ID: 23652844
[TBL] [Abstract][Full Text] [Related]
8. Role of the Apparent Diffusion Coefficient in the Prediction of Response to Neoadjuvant Chemotherapy in Patients With Locally Advanced Breast Cancer.
Bufi E; Belli P; Costantini M; Cipriani A; Di Matteo M; Bonatesta A; Franceschini G; Terribile D; Mulé A; Nardone L; Bonomo L
Clin Breast Cancer; 2015 Oct; 15(5):370-80. PubMed ID: 25891905
[TBL] [Abstract][Full Text] [Related]
9. MRI-Based Apparent Diffusion Coefficient for Predicting Pathologic Response of Rectal Cancer After Neoadjuvant Therapy: Systematic Review and Meta-Analysis.
Amodeo S; Rosman AS; Desiato V; Hindman NM; Newman E; Berman R; Pachter HL; Melis M
AJR Am J Roentgenol; 2018 Nov; 211(5):W205-W216. PubMed ID: 30240291
[TBL] [Abstract][Full Text] [Related]
10. Apparent Diffusion Coefficient Can Predict Therapy Response of Hepatocellular Carcinoma to Transcatheter Arterial Chemoembolization.
Drewes R; Heinze C; Pech M; Powerski M; Woidacki K; Wienke A; Surov A; Omari J
Dig Dis; 2022; 40(5):596-606. PubMed ID: 34749359
[TBL] [Abstract][Full Text] [Related]
11. Assessment of early treatment response to neoadjuvant chemotherapy in breast cancer using non-mono-exponential diffusion models: a feasibility study comparing the baseline and mid-treatment MRI examinations.
Bedair R; Priest AN; Patterson AJ; McLean MA; Graves MJ; Manavaki R; Gill AB; Abeyakoon O; Griffiths JR; Gilbert FJ
Eur Radiol; 2017 Jul; 27(7):2726-2736. PubMed ID: 27798751
[TBL] [Abstract][Full Text] [Related]
12. Diffusion-weighted magnetic resonance imaging for pretreatment prediction and monitoring of treatment response of patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy.
Nilsen L; Fangberget A; Geier O; Olsen DR; Seierstad T
Acta Oncol; 2010 Apr; 49(3):354-60. PubMed ID: 20397769
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of pretreatment ADC values as predictors of treatment response to neoadjuvant chemotherapy in patients with breast cancer - a multicenter study.
Surov A; Pech M; Meyer HJ; Bitencourt AGV; Fujimoto H; Baxter GC; Santamaría G; Gilbert FJ; Wienke A
Cancer Imaging; 2022 Dec; 22(1):68. PubMed ID: 36494872
[TBL] [Abstract][Full Text] [Related]
14. Impact of Machine Learning With Multiparametric Magnetic Resonance Imaging of the Breast for Early Prediction of Response to Neoadjuvant Chemotherapy and Survival Outcomes in Breast Cancer Patients.
Tahmassebi A; Wengert GJ; Helbich TH; Bago-Horvath Z; Alaei S; Bartsch R; Dubsky P; Baltzer P; Clauser P; Kapetas P; Morris EA; Meyer-Baese A; Pinker K
Invest Radiol; 2019 Feb; 54(2):110-117. PubMed ID: 30358693
[TBL] [Abstract][Full Text] [Related]
15. Diffusion-weighted imaging for determining response to neoadjuvant therapy in pancreatic cancer: a systematic review and meta-analysis.
Bilreiro C; Andrade L; Marques RM; Matos C
Eur Radiol; 2024 May; 34(5):3238-3248. PubMed ID: 37907761
[TBL] [Abstract][Full Text] [Related]
16. Intravoxel incoherent motion diffusion-weighted MRI for predicting response to neoadjuvant chemotherapy in breast cancer.
Kim Y; Kim SH; Lee HW; Song BJ; Kang BJ; Lee A; Nam Y
Magn Reson Imaging; 2018 May; 48():27-33. PubMed ID: 29278762
[TBL] [Abstract][Full Text] [Related]
17. Apparent Diffusion Coefficient Value to Evaluate Tumor Response After Neoadjuvant Chemotherapy in Patients with Breast Cancer.
Ramírez-Galván YA; Cardona-Huerta S; Elizondo-Riojas G; Álvarez-Villalobos NA
Acad Radiol; 2018 Feb; 25(2):179-187. PubMed ID: 29033147
[TBL] [Abstract][Full Text] [Related]
18. Apparent diffusion coefficient cannot discriminate metastatic and non-metastatic lymph nodes in rectal cancer: a meta-analysis.
Surov A; Meyer HJ; Pech M; Powerski M; Omari J; Wienke A
Int J Colorectal Dis; 2021 Oct; 36(10):2189-2197. PubMed ID: 34184127
[TBL] [Abstract][Full Text] [Related]
19. Early prediction of response to neoadjuvant chemotherapy in patients with breast cancer using diffusion-weighted imaging and gray-scale ultrasonography.
Iwasa H; Kubota K; Hamada N; Nogami M; Nishioka A
Oncol Rep; 2014 Apr; 31(4):1555-60. PubMed ID: 24535214
[TBL] [Abstract][Full Text] [Related]
20. Diffusion-weighted MRI Findings Predict Pathologic Response in Neoadjuvant Treatment of Breast Cancer: The ACRIN 6698 Multicenter Trial.
Partridge SC; Zhang Z; Newitt DC; Gibbs JE; Chenevert TL; Rosen MA; Bolan PJ; Marques HS; Romanoff J; Cimino L; Joe BN; Umphrey HR; Ojeda-Fournier H; Dogan B; Oh K; Abe H; Drukteinis JS; Esserman LJ; Hylton NM;
Radiology; 2018 Dec; 289(3):618-627. PubMed ID: 30179110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
